46results about How to "Lower blood cholesterol levels" patented technology

Methods, devices, and compositions relating to processed grain products are disclosed. An exemplary method disclosed is a fiber separation process for the ethanol industry corn products of Distillers Dried Grains (DDG) and Distillers Dried Grains with Solubles (DDGS) resulting from the widely used dry grind technology. A disclosed process and apparatus allows the removal and separate recovery of fiber-reduced DDG or DDGS products with expanded potential for use as a non-ruminant feed product in addition to the removal and separate recovery of a fiber-enriched product. The specific processes, devices, and compositions disclosed are readily adaptable to modern ethanol production plants.

An ester formed from an inositol or an inositol derivative and niacin, wherein the inositol or the inositol derivatives comprises a stereoisomer selected from allo-inositol, cis-inositol, epi-inositol, muco-inositol, neo-inositol, scyllo-inositol, D-chiro-inositol and L-chiro-inositol, or pharmaceutically acceptable salts thereof. Examples of esters include inositol hexaniacinates such as allo-inositol hexaniacinate and cis-inositol hexaniacinate. The esters can be used to treat any disorder that is treatable with niacin therapy such as dyslipidemia, hypercholesterolemia, hyperlipidemia or cardiovascular disease. The esters can be administered with other agents such as HMG-CoA reductase inhibitors, statins, fibrates, activators of peroxisome proliferator activated receptors poli-cosanol, phytosterols, tocotrienols, calcium, bile acid sequestrants, guar gum and free niacin. The invention includes pharmaceutical compositions containing these compounds.

Methods, devices, and compositions relating to processed grain products are disclosed for ground corn flour, soybean meal, cottonseed meal, and wheat middlings. An exemplary method disclosed is a fiber separation process for the ethanol industry corn products of Distillers Dried Grains (DDG) and Distillers Dried Grains with Solubles (DDGS) resulting from the widely used dry grind technology. A disclosed process and apparatus allows the removal and separate recovery of fiber-reduced products with expanded potential for use as a non-ruminant feed product in addition to the removal and separate recovery of a fiber-enriched product. The fiber enriched and fiber reduced products each have uses in the feed industry. The specific processes, devices, and compositions disclosed are readily adaptable to feed mills.

The invention discloses a fiber biscuit for promoting the digestion function. The fiber biscuit comprises, by weight, 30-50 parts of self-raising flour, 10-15 parts of low-fat milk powder, 5-8 parts of bean dreg powder, 3-5 parts of hawthorn powder, 15-20 parts of egg liquid, 10-20 parts of butter and 5-8 parts of berry sugar. The fiber biscuit is free of pollution, safe, free of toxic and side effects and free of annexing agents, and has the advantages of preventing and treating hypertension, heart diseases and arteriosclerosis, reducing the serum cholesterol concentration and promoting digestive absorption. The fiber biscuit is simple in making process, low in cost, high in production efficiency and suitable for large-scale production.

An animal model has been developed where the animals can survive myocardial infarctions caused by diet-induced coronary atherosclerosis, and live with chronic heart failure. This animal model is a result of reduced activity of scavenger receptor class BI (SR-BI) and ApoE and the inducible activity of the Mx1-Cre gene. In a preferred embodiment, the model is a result of crossbreeding two transgenic mouse lines: a knockout of SR-BI (SRBI− / −) and an impaired ApoE expressor (Apoeh / h) to generate a strain referred to as Apoeh / hSRB1− / − mice, which is then crossbred to mice that carry the inducible Mx1-Cre transgene. The Apoeh / hSRB1− / − mouse model is genetically modified, enabling the offspring to rapidly and permanently lower their high blood cholesterol levels caused by dietary challenge. The ability to rapidly and permanently lower blood cholesterol levels in these mice stops and may cause the regression of occlusive coronary atherosclerosis restoring blood flow to the heart, allowing the mice to survive from myocardial infarction and live with chronic heart failure.

The invention relates to a preparation method of a functional phytosteryl ester emulsion, and belongs to the technical field of food processing. The preparation method of the functional phytosteryl ester emulsion comprises the following steps: adding water into whey protein, and carrying out mixing so as to obtain a 3-5% protein solution; adding phytosteryl ester into the protein solution, and carrying out stirring until the phytosteryl ester is fully dissolved so as to obtain an aqueous phase; mixing the solution with corn germ oil so as to obtain a primary functional phytosteryl ester emulsion; and then, performing high-pressure homogenization treatment and high-pressure micro-jet homogenization treatment on the primary functional phytosteryl ester emulsion, so that the functional phytosteryl ester emulsion is prepared. The prepared functional phytosteryl ester emulsion is evenly distributed, and is good in stability. The functional phytosteryl ester emulsion is high in nutritive values, and has the functions of reducing cholesterol content in the blood, preventing cardiovascular diseases, inhibiting tumors, enhancing immunity and so on. The functional phytosteryl ester emulsion effectively exerts the functional characteristics of the phytosterol functional factors, so that the application of the phytosteryl ester in the foods is increased.

The invention relates to medicated diet powder for adjusting human body sub-health. The medicated diet powder comprises medicine materials and food materials. The medicine materials comprise ginseng, cornua cervi pantotrichum, fleece-flower roots, boschniakia rossica, Maca, polygala tenuifolia, calamus, poria with hostwood, fructus alpiniae oxyphyllae, lucid ganoderma, the fruits of Chinese magnoliavine, raw hawthorn fruits, gastrodia elata, rhizome of rehmannia, radix ophiopogonis, angelica sinensis, acanthopanax roots, pearls, black sesame, fossil fragments and oyster. The food materials comprise millet, walnut kernels, Chinese dates and lotus seeds. The matching ratio of the medicine materials to the food materials is 1:3. The formula is the environment-friendly additive-free composition screened through a large number of experiments and capable of supplanting brain nutrition. The medicated diet powder has the quite good conditioning effect on the sub-health status of middle-aged and aged people. The medicated diet powder for adjusting human body sub-health can achieve the effects of tonifying primordial Qi, adding kidney essence, calming heart and tranquilizing the mind, tonifying brain and improving intelligence, strengthening tendons and bones, improving immunity, resisting dementia, softening blood vessels, lowering blood fat, lowering cholesterol, delaying ageing, prolonging life and the like.

The invention provides a seafood sausage food, the seafood sausage is prepared from oysters serving as the main raw material and other auxiliary materials added. The invention also discloses a production method for an oyster sausage, the production method comprises the following steps of: removing fishy smell, boiling, mincing, blending, salting, chopping and mixing, performing sausage packing, sterilizing, cooling and the like. The oyster sausage provided by the invention is a food with strong seafood relish, rich nutrition, higher quality and nutrition value.

The invention discloses healthcare enriched rice containing corn and a preparation method thereof. The healthcare enriched rice containing corn is characterized by being prepared through the following steps: adding water in 70-30% of rice meal and 30-70% of corn meal, and mixing the rice meal and the corn meal to meal bulks, extruding the meal bulks into rice grains through a granulator, and drying the rice grains through microwave. According to the invention, the corn is added in the rice to prepare the faint yellow healthcare enriched rice with luster, the cooked rice is fine and soft, and the taste is good, so that the rice is suitable for the young and the oil; besides, the rice can not only provide heat, but also has sufficient nutrients, the rice contains seven nutritional and healthcare materials of fat, lecithin, grain alcohol, vitamin E, renieratene, riboflavin and vitamin B, and the rice has the functions of reducing the human blood cholesterol content and preventing hypertension and coronary heart disease.

The invention discloses breakfast cookies which are composed of the following ingredients by mass: 60kg of wheat flour, 10kg of barley flour, 2kg of walnut kernels, 1kg of eggs, 1kg of almonds, 1kg of sunflower seeds, 1kg of salt, 2kg of honey, 1kg of olive oil, 5kg of peanut oil and 15kg of milk. The breakfast cookies are prepared by the following steps of grinding the walnut kernels, the almonds and the sunflower seeds into powder, and screening the powder through a 120-mesh screen for later use; mixing and stirring the wheat flour, the barley flour, the walnut kernel powder, the almond powder, the sunflower seed powder, the eggs, the salt, the peanut oil, the olive oil, the honey and the milk, and making dough; making cookies according to a conventional method and baking the cookies. According to the breakfast cookies, coarse food grains are added reasonably, the nuts and the milk are also added, and therefore, balanced nutrition is achieved. Accordingly, the breakfast cookies are suitable for breakfast.

An animal model has been developed where the animals can survive myocardial infarctions caused by diet-induced coronary atherosclerosis, and live with chronic heart failure. This animal model is a result of reduced activity of scavenger receptor class BI (SR-BI) and ApoE and the inducible activity of the Mx1-Cre gene. In a preferred embodiment, the model is a result of crossbreeding two transgenic mouse lines: a knockout of SR-BI (SRBI− / −) and an impaired ApoE expressor (Apoeh / h) to generate a strain referred to as Apoeh / hSRB1− / − mice, which is then crossbred to mice that carry the inducible Mx1-Cre transgene. The Apoeh / hSRB1− / − mouse model is genetically modified, enabling the offspring to rapidly and permanently lower their high blood cholesterol levels caused by dietary challenge. The ability to rapidly and permanently lower blood cholesterol levels in these mice stops and may cause the regression of occlusive coronary atherosclerosis restoring blood flow to the heart, allowing the mice to survive from myocardial infarction and live with chronic heart failure.

The invention relates to the technical field of production of nutritional powder, and discloses a preparation method of nutritional cereal and vegetable powder. The method comprises the following steps of sequentially blanching, cooking, dehydrating, crushing, drying, grinding, mixing, sterilizing and packaging raw materials to obtain the nutritional cereal and vegetable powder. According to the preparation method of the nutritional cereal and vegetable powder, complete sterilization of the raw materials in sequence is guaranteed, and sterile production of the nutritional powder is guaranteed,so that the quality of the nutritional powder is guaranteed, the storage time of the nutritional powder is prolonged, and the eating safety of the nutritional powder is guaranteed; the preparation period is relatively short, so that the production efficiency is greatly improved; cereals and vegetables are perfectly combined, so that the nutrition of the nutritional powder is more sufficient, thenutritional powder not only can be used for satisfying hunger, but also can provide enough nutrition, and the nutritional ingredients of the nutritional powder are greatly improved; and the overall sugar content is relatively low, so that various people can eat the nutritional powder, and the eating limitation of the nutritional powder is greatly reduced.

A Chinese medicine in the form of dual-phase capsule for treating coronary heart disease is prepared from red sage root, notoginseng and dalbergia wood through extracting the volatile oil from dalbergi a wood, preparing its dripping pills, extracting the water-soluble and alcohol-soluble components from red sage root and notoginseng, preparing their particles and loading said dripping pills and particles is capsules.

The invention provides a milk for middle and old age, and a production method thereof, and relates to the technical field of dairy products. The milk for middle and old age comprises, by weight, 85-95parts of skimmed milk, 0.5-2.0 parts of dietary fibers, 1.0-2.0 parts of functional sugar, 0.1-0.2 part of milk mineral salt, 0.05-0.0833 part of composite vitamins, 0.1-0.2 part of soybean lecithin,0.1-0.22 part of phytosterol ester, 1-2 parts of a red date juice, 0.5-1 part of a wolfberry fruit juice, 0.4-0.5 part of an emulsifying stabilizer and 0.045-0.068 part of an edible essence. The production method comprises the following steps: primary batching, primary homogenization, pasteurization, secondary batching, secondary homogenization, high-temperature sterilization and cooling. The milk for middle and old age is optimally designed according to physiological characteristics and nutritional needs of middle-aged and aged people, is rich in nutrients, can effectively reduce the cholesterol level of human body blood, maintain the health of the heart, supplement calcium, prevent osteoporosis, supplement the intake of dietary fibers, improve the hyperglycemia of the of middle-aged andaged people, prevent and treat constipation, hemorrhoids and so on and prevent and treat modern civilized diseases, and has nutrition and health dual effects.

The invention belongs to the technical field of biological active peptides, and particularly relates to a cannabis sativa blood-fat-reducing peptide composition and application thereof. To solve the problem that cannabis sativa seed meal resources are under utilization, the cannabis sativa blood-fat-reducing peptide composition is provided. The cannabis sativa blood-fat-reducing peptide composition comprises a pentapeptide with the amino acid sequence of Val-Ser-Glu-Pro-Arg and a hexapeptide with the amino acid sequence of Ile-Asp-Lys-Phe-Ser-Arg, wherein the mass ratio of the pentapeptide tothe hexapeptide is 4:5. According to the cannabis sativa blood-fat-reducing peptide composition and the application thereof, cannabis sativa seed meal is subjected to enzymolysis and filtered by a 1KDultrafiltration membrane to obtain the small molecule peptide composition, the content of glutamic acid and arginine in the composition is high, and through the special amino acid sequences, the cannabis sativa blood-fat-reducing peptide composition has a significant function of blood fat adjustment during absorption and metabolism of the human body. The cannabis sativa blood-fat-reducing peptidecomposition is applied to blood-fat-reducing drugs, health-care foods and food additives, and can hinder cholesterol absorption in the intestinal tracts, and promote the process of discharging cholesterol out of the body, and thus the concentration of the serum cholesterol is lowered.

The present invention discloses nutritious potato and cereal grain vermicelli and relates to the technical field of food processing. The nutritious potato and cereal grain vermicelli consists of the following components in weight percentages: 20-30% of wheat, 50-70% of potatoes, 1-5% of radix puerariae, 1-2% parts of herba dendrobii, 1-5% of sunflower seeds, 1-2% of oats, 1-1.5% of pleurotus eryngii, 1-2% of coix chinensis and 0.5-1% of edible salt. A recipe of the vermicelli completely different from that of traditional vermicelli is used, so that the prepared potato vermicelli is rich in various nutrients and trace elements, and free of any additives, and can be stored at room temperature for a long time.

The invention discloses a lipid-lowering and healthcare liquor, comprising ginkgo biloba leaf 20-38, tuber of multiflower knotweed 20-38, radix glycyrrhiza 15-20, emblic leafflower fruit 20-65, gynostemma pentaphyllum 20-26, hawthorn 8-25, flower of Chinese scholartree 15-20, peppermint 10-20, and liquor 500-1000 whose alcoholic strength is 38-72, and then the lipid-lowering and healthcare liquor is extracted for 4 times, and each extracting time is 10-20 days, the extracted liquor from the 4-times extraction is combined and then is filtered, and edible sugar 15-25 is added to the solution, and then, the manufacture of the lipid-lowering and healthcare liquor is completed. The advantages of the invention are as follows: the compatibility of various medicinal materials is reasonable; the comprehensive function of the medicinal materials can be played to the utmost extent, the efficacy of the medicinal materials can be played to the utmost extend through special extraction process; and the lipid-lowering and healthcare liquor has ideal lipid-lowering and healthcare function, and has good cardiovascular healthcare and blood-pressure lowering function.

Blood cholesterol levels are correlated with production of amyloid β protein (Aβ), and are predictors of populations at risk of developing AD. Methods for lowering blood cholesterol levels can be used to decrease production of Aβ, thereby decreasing the risk of developing AD. The same methods and compositions can also be used for treating individuals diagnosed with AD. Methods include administration of compounds which increase uptake of cholesterol by the liver, such as the administration of HMG CoA reductase inhibitors, administration of compounds which block endogenous cholesterol production, such as administration of HMG CoA reductase inhibitors, administration of compositions which prevent uptake of dietary cholesterol, and administration of combinations of any of these which are effective to lower blood cholesterol levels. Methods have also been developed to predict populations at risk, based on the role of cholesterol in production of Aβ. For example, individuals with Apo E4 and high cholesterol, defined as a blood cholesterol level of greater than 200 mg / dl, post menopausal women with high cholesterol levels—especially those who are not taking estrogen, or individuals which high blood cholesterol levels who are not obese are all at risk of developing AD if blood cholesterol levels are not decreased.

The invention discloses an LGR4 gene / protein for screening medicine for treating hypercholesteremia. The LGR4 gene serves as a molecular target or medicine acting target, and is used for screening or preparing the medicine for treating hypercholesteremia and low-density lipoprotein cholesterin. The new application of the glycoprotein hormone receptor LGR4 gene in a G protein-coupled receptor is provided, a new target is provided for treatment on hypercholesteremia and high density lipoprotein and low-density lipoprotein cholesterol (LDL-c) adaptation diseases, and good application prospects are achieved.

The invention relates to infant nutrition comprising large lipid globules. This infant nutrition has programming effects on the body and results in a reduced level of total blood cholesterol later in life when consuming a Western style diet. Thereby the risk on western life style diseases as atherosclerosis and other vascular diseases later in life can be reduced.

The present invention discloses papaya cool drink and a preparation method thereof. The papaya cool drink is prepared from the following raw materials: papaya leaves, papaya peels, papaya flesh, papaya seeds, lotus rhizome nodes and nymphaea tetragona flowers. The papaya peels, papaya leaf powder, papaya seeds, lotus rhizome node powder and nymphaea tetragona flowers are subjected to extracting and concentrating at a ratio of (4-6):(3-5):(1-3):(2-3):(0.5-1.5); and (5-7) g of papaya flesh powder is added into every (90-110) g of the concentrated extract to be mixed evenly to prepare the papayacool drink. A regular drinking of the papaya cool drink has many health-care effects on eliminating fatigue, strengthening spleen, promoting digestion, clearing heat, relieving toxins, etc., and is especially excellent for postpartum women.

The invention provides a prescription for treating hyperlipidemia. The prescription comprises, by weight, 30g of herba artemisiae scopariae, 20g of fructus crataegi and 15g of raw fructus hordei germinatus. The prescription for treating the hyperlipidemia has the advantages that the prescription is applicable to patients, of different ages, with the hyperlipidemia; the prescription is capable of lowering blood cholesterol content so as to allow the transportation, metabolism and discharge of blood cholesterol to be easy, reducing cholesterol content in plasma, changing the distribution of cholesterol in a human body at the same time, reducing the cholesterol content in blood vessel walls, allowing most of cholesterol to precipitate in tissue outside the blood vessel walls, and finally allowing hyperlipidemia symptoms to disappear.

The invention belongs to the technical field of bioactive peptides, and in particular relates to a hemp-lowering blood lipid peptide composition and its application. In order to solve the problem of insufficient utilization of hemp seed meal resources, the present invention provides a hemp lipid-lowering peptide composition, comprising a pentapeptide with an amino acid sequence of Val-Ser-Glu-Pro-Arg in a mass ratio of 4:5 and The amino acid sequence is a hexapeptide of Ile-Asp-Lys-Phe-Ser-Arg. In the present invention, the content of glutamic acid and arginine in the small molecule peptide composition obtained by enzymatic hydrolysis and 1KD ultrafiltration membrane filtration of hemp seed meal is relatively high, and the special amino acid sequence enables the hemp blood lipid-lowering peptide composition to be absorbed and metabolized by the human body The hemp-lowering lipid peptide composition of the present invention is applied to blood-lipid-lowering medicines, health food and food additives, which can hinder the absorption of cholesterol in the intestinal tract, promote the excretion of cholesterol, thereby reducing blood cholesterol concentration .

The invention provides a traditional Chinese medicine composition for treating hyperlipemia and fatty liver, and a preparation method thereof. The traditional Chinese medicine composition is prepared from, by weight, 10-25 parts of semen cassiae, 10-25 parts of sweet wormwood herb, 10-40 parts of agilawood, 10-20 parts of radix curcumae, 5-20 parts of radix gentianae, 1-15 parts of pericarpium citri reticulatae viride, 5-15 parts of radix paeoniae rubra, 5-25 parts of geranium wilfordii and 5-20 parts of fructus psoraleae. The traditional Chinese medicine composition disclosed by the invention can effectively relieve and / or eliminate dizziness, head skin, acne rosacea, flushing complexion, hypochondriac distending pain and other hyperlipidaemia and fatty liver patient clinical symptoms, the effective rate is as high as 89.5%, and a new choice is provided for clinical medication.

Belonging to the health food field, the invention relates to an American ginseng composition capable of improving immunity, a preparation method and application thereof. Directed at the problem of poor absorption effect in existing American ginseng products, the invention provides an American ginseng composition capable of improving immunity. The American ginseng composition is prepared from the following raw materials by weight: 1 part of American ginseng, 2-3 parts of xylitol and 0.1-0.2 part of vitamin C. Specifically, the American ginseng is subjected to ultrafine grinding, and then the product is mixed with xylitol and vitamin C, thus obtaining the composition. The American ginseng composition provided by the invention can be used for development and production of drugs or health products for improving immunity.